Skip to main content

Incannex Healthcare Inc

For the period ended Jun 30, 2024. Filed Sep 30, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Sep 30, 2024

IXHL$2.01-8.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Power of Attorney (included on the signature page hereto)

POWER OF ATTORNEY

IN WITNESS WHEREOF, each person whose signature appears below constitutes and appoints Joel Latham and Joseph Swan as his true and lawful agent, proxy and attorney-in-fact, each acting alone, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to (i) act on and sign any amendments to this report, with exhibits thereto and other documents in connection therewith, (ii) act on and sign such certificates, instruments, agreements and other documents as may be necessary or appropriate in connection therewith, and in each case file the same with the SEC, hereby approving, ratifying and confirming all that such agent, proxy and attorney-in-fact or any of his substitutes may lawfully do or cause to be done by virtue thereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

NamePositionDate
/s/ Joel LathamChief Executive Officer, President and DirectorSeptember 30, 2024
Joel Latham(principal executive officer)
/s/ Joseph SwanChief Financial OfficerSeptember 30, 2024
Joseph Swan(principal financial and accounting officer)
/s/ Troy ValentineDirectorSeptember 30, 2024
Troy Valentine
/s/ Peter WiddowsDirectorSeptember 30, 2024
Peter Widdows
/s/ George AnastassovDirectorSeptember 30, 2024
George Anastassov
/s/ Robert ClarkDirectorSeptember 30, 2024
Robert Clark
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.